Last updated 2026-07-20
Total raised
—
Last: Grant 2015-12
Stage
Pre-Funding
Founded
2013
Headcount
2
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
BrainFulness has developed a new technology for treating major depression, ADHD, and dementia with no side effects. The company has built a working prototype of its technology and registered for patents in Israel, the United States, Germany, and Japan. The prototype was approved for human use by the Israeli Health Ministry, and BrainFulness has completed a clinical trial on chronic, treatment-resistant patients, yielding encouraging results without side effects. The device is a low-cost, innovative, non-invasive device for home treatment of major depression and chronic anxiety, based on Repetitive Triggered Somatosensory Discrimination (RTSD) technology.
Headcount over time
2 employees (2026-09) · 1 point
Offices
Jerusalem, Israel · HQ / main office
Q&A
- What is BrainFulness's primary focus?
- BrainFulness focuses on developing new technology for treating major depression, ADHD, and dementia without side effects.
- When was BrainFulness founded?
- BrainFulness was founded in September 2015.
- What is the current employee count for BrainFulness?
- BrainFulness has 1-10 employees.
- Has BrainFulness secured any funding?
- Yes, BrainFulness received a Grant round of $55,000 in December 2015 from Israel Innovation Authority.
- What is BrainFulness's current funding stage?
- BrainFulness is currently in the Pre-Funding stage.
- Has BrainFulness registered any patents?
- Yes, BrainFulness has registered for patents in Israel, the United States, Germany, and Japan.
- Has BrainFulness conducted clinical trials?
- BrainFulness has completed a clinical trial on chronic, treatment-resistant patients, yielding encouraging results without side effects, after its prototype was approved for human use by the Israeli Health Ministry.
- Who are the founders of BrainFulness?
- The founders of BrainFulness are Prof. Haim Knobler and Abraham Shoshani.
Team · 9
Haim Knobler
Founder · Founder & Advisor
Abraham Shoshani
Founder · Chairman, Director of Scientific Research and Development
Gerard Henzen
Founder · COO & BizDev Manager
Gregory Katz
Chief Science Officer, Researcher
Nuriel Shoshani
Chief Financial Officer
Talya Miller
CEO A.I.
Ayala Ashkenazi
Vice CEO, Project Management
Roman Galay
Chief Financial Advisor
Oded Talmon
Industrial Engineer, IT Expert and Business Consultant
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2C
Highlights
1 PatentsVerified
Tags
medical-devicesmental-healthpatientsnon-invasiveconsumers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | brainfulnessltd.com/ |
|---|---|
| linkedin.com/company/11830501 | |
| facebook.com/pages/category/Biotechnology-Company/Brainfulne |
Identifiers & details
| Founded | 2013 |
|---|---|
| Employees (exact) | 2 |
Radar intelligence
Web history (Wayback)
| Domain | brainfulnessltd.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515322899 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-11-25 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 4 — annual_report (3), violation (1) |
| Registered address | אגמון 2 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2025-08-11 | דו~ח שנתי |
| 2025-08-04 | עדכון הפרה |
| 2026-06-03 | דו~ח שנתי-הקצאת מניות |
| 2026-06-03 | דו~ח שנתי-עדכון בעלי מניות |